Shankar Biswas, Yashasvi Srivastava, Rahul Falodia, Ayman Hamadttu. "Real-world effectiveness and safety of amivantamab plus chemotherapy versus chemotherapy alone in EGFR-mutant NSCLC after osimertinib: A propensity score–matched analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.284